CEO Matthew Weinberg Presents at FDA Clinical Trials Hearing
April 23 - The Weinberg Group CEO, Matthew Weinberg, presented today at FDA’s hearing titled “Modernizing the Regulation of Clinical Trials and Approaches to Good Clinical Practice.” Mr. Weinberg...
Matthew Weinberg Quoted in Article about EMA’s Initiative to Broaden Expert Involvement with Updated Policy on Conflicts of Interest
FDANews Drug Industry Daily Nov. 21, 2014 Europe’s drug regulatory agency has revised the conflict of interest policy for its scientific committee members and experts, a move that one attorney says...
Matthew Weinberg Writes for International Clinical Trials (ICT) Magazine
In this article CEO Matthew Weinberg discusses the downsides to self-auditing good clinical practice and the need smaller, more proactive audits, on the other hand, can provide a more intelligent...